Claritev Raises Full-Year Guidance After Earnings Beat

Claritev (CTEV) reported fiscal 2026 Q2 earnings on Aug 07th, 2026. The company delivered financial results that exceeded analyst expectations, with revenue of $257.5 million surpassing the consensus of $243.3 million. Adjusted EPS of -$3.49 beat estimates by $0.67. The company raised its full-year revenue guidance to $1 billion-$1.02 billion, reflecting a positive outlook for the remainder of the fiscal year.

Revenue

The total revenue of Claritev increased by 6.6% to $257.48 million in 2026 Q2, up from $241.57 million in 2025 Q2. Within this growth, Claims intelligence solutions led the performance with $178.47 million, while Network solutions contributed $50.33 million. Payment and revenue integrity solutions added $28.68 million, bringing the Total revenue to $257.48 million.

Earnings/Net Income

Claritev narrowed losses to $3.49 per share in 2026 Q2 from a loss of $3.81 per share in 2025 Q2 (8.4% improvement). Meanwhile, the company successfully narrowed its net loss to $-59.23 million in 2026 Q2, reducing losses by 5.5% compared to the $-62.64 million net loss reported in 2025 Q2. The adjusted EPS beat consensus estimates, signaling improved operational efficiency despite ongoing net losses.

Price Action

The stock price of Claritev has jumped 11.86% during the latest trading day, has surged 43.51% during the most recent full trading week, and has edged up 1.78% month-to-date.

Post Earnings Price Action Review

The market reacted positively to Claritev's fiscal 2026 Q2 results, with the stock jumping 11.86% on the latest trading day and surging 43.51% over the most recent full trading week, despite only edging up 1.78% month-to-date. While a clean, rules-based backtest of a "revenue-beat then hold 30 days" strategy is not feasible due to missing consensus data, a proxy comparison using SOXX indicates that CTEV’s price action was broadly aligned with the semiconductor sector, rising 120.5% from January 2, 2025, to August 7, 2026, versus 152.11% for SOXX. To properly evaluate such strategies, one would need a verified earnings calendar, revenue consensus estimates, and strict trade rules including entry, exit, and stop-loss parameters.

CEO CommentaryTravis Dalton, President and Chief Executive Officer, highlighted strong Q2 performance, noting revenue and adjusted EBITDA exceeded expectations, with bookings surpassing $70 million ACV for the first half of 2026. He emphasized the success of horizontal solutions in vertical markets, particularly the TPA segment’s contribution of seven-figure deals like Marpi. Dalton positioned AI as a critical accelerator, leveraging Claritev’s modernized data architecture to improve efficiency in NSA claims processing and operational workflows. He expressed optimism about the company’s turnaround, citing improved leadership alignment, technological investments, and a culture of growth. Dalton remained optimistic, asserting that the strategy is working, execution is strengthening, and the company is building forward momentum to achieve sustainable long-term value through diversified growth and debt reduction.

Guidance

Claritev raised its full-year revenue guidance to $1 billion-$1.02 billion, reflecting 4%-6% growth, and increased adjusted EBITDA guidance to $610 million-$620 million, targeting margins of approximately 61%. Free cash flow guidance was raised by $5 million to a new range of $5 million-$15 million. Capital expenditures remain unchanged at $160 million-$170 million. Management expects Q3 revenue to be flat sequentially, with full-year growth driven by Claims Intelligence, particularly NSA volumes. The company anticipates continuing investments in sales and operations to support new bookings, which are projected to exceed $100 million ACV. Adjusted cash conversion is expected to normalize to over 50% by year-end, supporting deleveraging and organic growth initiatives.